(S)-1-(2-Methoxyphenyl)ethanamine

Catalog No.: 
ACLDWR180
CAS No.: 
68285-24-5
Molecular Formula: 
C9H13NO
Molecular Weight: 
151.21
(S)-1-(2-Methoxyphenyl)ethanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$65.00In stockIn stock
5g95%$222.00In stockIn stock
25g95%$1077.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-1-(2-Methoxyphenyl)ethanamine
IUPAC Name(S)-1-(2-methoxyphenyl)ethan-1-amine
MDL No.MFCD00671658
Molecular FormulaC9H13NO
Molecular Weight151.21
SMILESC[C@H](N)C1=CC=CC=C1OC
InChI KeyVENQOHAPVLVQKV-ZETCQYMHSA-N
Synonym(S)-(-)-2-Methoxy a-methylbenzylamine | EN300-87753 | (1S)-1-(2-methoxyphenyl)ethylamine | (1S)-1-(2-methoxyphenyl)-ethylamine | AKOS010377903 | (S)-2-Methoxy-alpha-methylbenzylamine, ChiPros(R), produced by BASF, 99% | (1S)-1-(2-methoxyphenyl)ethanamine
CAS No.68285-24-5
PubChem CID853082

Safety Data

Pictogram
CorrosiveToxic
Signal Word
Danger
Hazard Statement(s)
H314-H331
Precautionary Statement(s)
P261-P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACLDWR180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSVYE659 route compound structure diagram
    ACSVYE659579-74-8In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACLDWR180 route product structure diagram
    ACLDWR18068285-24-5In Stock
Inquiry

2. ACLDWR180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLDWR180 route product structure diagram
    ACLDWR18068285-24-5In Stock
Inquiry

3. ACLDWR180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLDWR180 route product structure diagram
    ACLDWR18068285-24-5In Stock
Inquiry

Comments (0)